AU6167296A - Monoclonal antibody fragment to human ovarian cancers - Google Patents
Monoclonal antibody fragment to human ovarian cancersInfo
- Publication number
- AU6167296A AU6167296A AU61672/96A AU6167296A AU6167296A AU 6167296 A AU6167296 A AU 6167296A AU 61672/96 A AU61672/96 A AU 61672/96A AU 6167296 A AU6167296 A AU 6167296A AU 6167296 A AU6167296 A AU 6167296A
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibody
- antibody fragment
- human ovarian
- ovarian cancers
- cancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47819095A | 1995-06-07 | 1995-06-07 | |
US478190 | 1995-06-07 | ||
PCT/US1996/009819 WO1996040295A1 (en) | 1995-06-07 | 1996-06-07 | Monoclonal antibody fragment to human ovarian cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6167296A true AU6167296A (en) | 1996-12-30 |
Family
ID=23898888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU61672/96A Abandoned AU6167296A (en) | 1995-06-07 | 1996-06-07 | Monoclonal antibody fragment to human ovarian cancers |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6167296A (en) |
WO (1) | WO1996040295A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6376654B1 (en) | 1999-08-13 | 2002-04-23 | Molecular Discoveries, Llc | Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
US7226750B1 (en) | 2000-08-08 | 2007-06-05 | Molecular Discoveries, Inc. | Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
KR100576674B1 (en) * | 2001-06-20 | 2006-05-10 | 제넨테크, 인크. | Compositions and Methods for the Diagnosis and Treatment of Tumor |
US6987270B2 (en) | 2003-05-07 | 2006-01-17 | General Electric Company | Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes |
-
1996
- 1996-06-07 AU AU61672/96A patent/AU6167296A/en not_active Abandoned
- 1996-06-07 WO PCT/US1996/009819 patent/WO1996040295A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO1996040295A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9504344D0 (en) | Antibody fragment production | |
AU5365296A (en) | Human monoclonal antibody against lung carcinoma | |
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
AU1704099A (en) | Monoclonal human natural antibodies | |
AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
HUP0104604A3 (en) | Human monoclonal antibodies to ctla-4 | |
AU5869596A (en) | Anti-gp130 monoclonal antibodies | |
IL128406A0 (en) | Monoclonal antibodies | |
IL130864A0 (en) | Monoclonal antibodies to human cd6 | |
AU1289795A (en) | Monoclonal antibodies specific for human interleukin-5 | |
EP0870826A4 (en) | Novel protein and monoclonal antibody specific thereto | |
AU6702998A (en) | Anti-alphabeta3 humanized monoclonal antibodies | |
AU7072998A (en) | Immunoassays using anti-allotypic monoclonal antibodies | |
AU6155896A (en) | Humanized antibodies to e-selectin | |
EP0977590A4 (en) | Human monoclonal antibodies | |
AU5021796A (en) | Recombinant human anti-lewis b antibodies | |
AU4256096A (en) | Monoclonal antibody fragments having immunosuppressant activity | |
AU4450389A (en) | Anti-fucosylcermiade monoclonal antibody | |
AU3923293A (en) | Human monoclonal antibodies and methods for human monoclonal antibody production | |
AU6167296A (en) | Monoclonal antibody fragment to human ovarian cancers | |
AU1809695A (en) | Tumor associated monoclonal antibody 123av16 | |
AU6777594A (en) | Human monoclonal antibodies to human cytomegalovirus, and methods therefor | |
AU2169797A (en) | Improved production of antibodies through the use of antigen antibody complexes | |
AU3008892A (en) | Tumor associated monoclonal antibody 88bv59 | |
GB9506425D0 (en) | New uses of monoclonal antibodies |